Olivia Phung, PharmD
Assistant Professor of Pharmacy Practice and Administration
College of Pharmacy
Phone: (909) 469-8205
Doctor of Pharmacy, 2008, Northeastern University, Boston, MA
Outcomes Research Fellowship, 2010, University of Connecticut and Hartford Hospital, Hartford, CT
Dr. Phung received her PharmD from Northeastern University and completed a two-year Outcomes Research Fellowship at the University of Connecticut/Hartford Hospital Evidence-Based Practice Center. She is trained in conducting systematic reviews and meta-analyses, with research interest specifically in treatment of diabetes and other metabolic syndromes.
Western University Patient Care Center
795 E. Second St. Suite 5
Pomona, CA 91766
Dr. Phung practices ambulatory care pharmacy at the WesternU Patient Care Center. She precepts students in ambulatory care, where they work closely with DO and PA students to provide care to patients seen by family medicine providers. She also provides diabetes education to patients seen by family and internal medicine providers and works closely with the Western Diabetes Institute.
Dr. Phung is interested in teaching evidence-based clinical practice and research methodology. Her research expertise lies in conducting systematic reviews and meta-analyses (including Bayesian mixed-treatment comparison), with emphasis in the treatment of diabetes and other aspects of the metabolic syndrome.
Phung OJ, Sood NA, Sill BE, Coleman CI. Oral antidiabetic drugs for the prevention of type 2 diabetes mellitus. Diabetic Medicine. 2011;28:948-964.
Phung OJ, Kahn SR, Cook DJ, Murad MH. Dosing frequency of unfractionated heparin thromboprophylaxis: a meta-analysis. Chest. 2011 Feb 24, epub ahead of print.
Phung OJ, Baker WL, Baker EL, Coleman CI. Barriers to updating systematic reviews: results from an internet survey. Journal of Investigative Medicine. 2011 Feb 18, epub ahead of print.
Phung OJ, Coleman CI, Baker EL, Scholle JM, Girotto JE, Makanji SS, Chen WT, Talati R, Kluger J, Quercia R, Mather J, Giovenale S, White CM. Effectiveness of recombinant human growth hormone (rhGH) in the treatment of patients with cystic fibrosis. Rockville, MD, Agency for Healthcare Research and Quality; 2010 Oct. Report No.: 11-EHC003-EF.
Phung OJ, Coleman CI, Baker EL, Scholle JM, Girotto JE, Makanji SS, Chen WT, Talati R, Kluger J, Quercia R, Mather J, Giovenale S, White CM. Effectiveness of recombinant human growth hormone (rhGH) in the treatment of patients with cystic fibrosis. Pediatrics. 2010;126:e1211-26.